Tumor target drug gastrin-releasing peptide receptor (GRPR) antagonist RC-3095 reduces the secretion of NGF in COAD cells, suggesting that the reduction of neurotrophin secretion is a potential mechanism for the anti-proliferation effect of GRPR antagonists (37). This evidence concerns the gene NGF and neoplasm.